HEADER TRANSFERASE 25-APR-19 6OPI TITLE PHOSPHORYLATED ERK2 WITH SCH-CPD336 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MAPK 1,ERT1,EXTRACELLULAR SIGNAL-REGULATED KINASE 2,ERK-2, COMPND 5 MAP KINASE ISOFORM P42,P42-MAPK,MITOGEN-ACTIVATED PROTEIN KINASE 2, COMPND 6 MAPK 2; COMPND 7 EC: 2.7.11.24; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK1, ERK2, PRKM1, PRKM2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ERK 2, MITOGEN ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, SIGNALING KEYWDS 2 PROTEIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.P.VIGERS,D.SMITH REVDAT 6 23-OCT-24 6OPI 1 REMARK REVDAT 5 15-NOV-23 6OPI 1 REMARK REVDAT 4 11-OCT-23 6OPI 1 REMARK REVDAT 3 18-DEC-19 6OPI 1 REMARK REVDAT 2 14-AUG-19 6OPI 1 JRNL REVDAT 1 31-JUL-19 6OPI 0 JRNL AUTH L.M.PEGRAM,J.C.LIDDLE,Y.XIAO,M.HOH,J.RUDOLPH,D.B.IVERSON, JRNL AUTH 2 G.P.VIGERS,D.SMITH,H.ZHANG,W.WANG,J.G.MOFFAT,N.G.AHN JRNL TITL ACTIVATION LOOP DYNAMICS ARE CONTROLLED BY JRNL TITL 2 CONFORMATION-SELECTIVE INHIBITORS OF ERK2. JRNL REF PROC.NATL.ACAD.SCI.USA V. 116 15463 2019 JRNL REFN ESSN 1091-6490 JRNL PMID 31311868 JRNL DOI 10.1073/PNAS.1906824116 REMARK 2 REMARK 2 RESOLUTION. 3.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0238 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 8226 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 410 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.08 REMARK 3 REFLECTION IN BIN (WORKING SET) : 578 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE SET COUNT : 29 REMARK 3 BIN FREE R VALUE : 0.2970 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2662 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 50 REMARK 3 SOLVENT ATOMS : 30 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.00000 REMARK 3 B22 (A**2) : 0.10000 REMARK 3 B33 (A**2) : -2.10000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.459 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.356 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.683 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.884 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2779 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2567 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3768 ; 1.741 ; 1.673 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5968 ; 1.187 ; 1.576 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 322 ; 7.395 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 150 ;32.730 ;22.467 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 491 ;18.279 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;25.127 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 352 ; 0.061 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3026 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 551 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1300 ; 3.706 ; 4.893 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1299 ; 3.698 ; 4.892 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1618 ; 5.700 ; 7.321 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1619 ; 5.699 ; 7.322 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1479 ; 3.678 ; 5.111 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1423 ; 3.696 ; 5.161 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2069 ; 5.829 ; 7.635 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3110 ; 8.002 ;56.022 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3026 ; 8.045 ;56.444 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6OPI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-APR-19. REMARK 100 THE DEPOSITION ID IS D_1000241142. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-AUG-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8550 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.16 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.34300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2ERK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% (W/V) PEG3350, 100 MM NA REMARK 280 CACODYLATE PH 7.2, 600 MM NACL, 10 MM MNCL2, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.69700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 63.26800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 38.82000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 63.26800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.69700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 38.82000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 5 REMARK 465 GLY A 6 REMARK 465 ALA A 7 REMARK 465 HIS A 176 REMARK 465 ASP A 177 REMARK 465 HIS A 178 REMARK 465 THR A 179 REMARK 465 GLY A 180 REMARK 465 PHE A 181 REMARK 465 LEU A 182 REMARK 465 TPO A 183 REMARK 465 GLU A 184 REMARK 465 PTR A 185 REMARK 465 VAL A 186 REMARK 465 ALA A 187 REMARK 465 SER A 200 REMARK 465 LYS A 201 REMARK 465 GLY A 202 REMARK 465 TYR A 203 REMARK 465 THR A 204 REMARK 465 LYS A 328 REMARK 465 PHE A 329 REMARK 465 ASP A 330 REMARK 465 MET A 331 REMARK 465 GLY A 355 REMARK 465 TYR A 356 REMARK 465 ARG A 357 REMARK 465 SER A 358 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 351 CG - CD - NE ANGL. DEV. = 15.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 13 60.68 35.03 REMARK 500 TYR A 28 122.25 -37.66 REMARK 500 THR A 108 -176.85 178.38 REMARK 500 SER A 140 -9.69 -55.55 REMARK 500 ARG A 146 -2.79 76.41 REMARK 500 ASP A 147 38.11 -146.77 REMARK 500 ASP A 165 93.69 71.03 REMARK 500 ASP A 173 84.08 -176.33 REMARK 500 PRO A 174 -17.43 -44.27 REMARK 500 LEU A 198 -128.79 -104.27 REMARK 500 PHE A 226 71.01 -117.70 REMARK 500 CYS A 252 20.44 -67.91 REMARK 500 LEU A 256 -77.62 60.00 REMARK 500 SER A 264 -1.93 -57.97 REMARK 500 LEU A 292 48.24 -86.53 REMARK 500 ASP A 335 79.25 -113.78 REMARK 500 ARG A 351 0.42 -63.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue N0V A 401 DBREF 6OPI A 6 358 UNP P28482 MK01_HUMAN 8 360 SEQADV 6OPI SER A 5 UNP P28482 EXPRESSION TAG SEQRES 1 A 354 SER GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL PHE SEQRES 2 A 354 ASP VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE GLY SEQRES 3 A 354 GLU GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP ASN SEQRES 4 A 354 VAL ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER PRO SEQRES 5 A 354 PHE GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG GLU SEQRES 6 A 354 ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE ILE SEQRES 7 A 354 GLY ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU GLN SEQRES 8 A 354 MET LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU THR SEQRES 9 A 354 ASP LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER ASN SEQRES 10 A 354 ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG GLY SEQRES 11 A 354 LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG ASP SEQRES 12 A 354 LEU LYS PRO SER ASN LEU LEU LEU ASN THR THR CYS ASP SEQRES 13 A 354 LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA ASP SEQRES 14 A 354 PRO ASP HIS ASP HIS THR GLY PHE LEU TPO GLU PTR VAL SEQRES 15 A 354 ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU ASN SEQRES 16 A 354 SER LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER VAL SEQRES 17 A 354 GLY CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO ILE SEQRES 18 A 354 PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS ILE SEQRES 19 A 354 LEU GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU ASN SEQRES 20 A 354 CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SER SEQRES 21 A 354 LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU PHE SEQRES 22 A 354 PRO ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP LYS SEQRES 23 A 354 MET LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL GLU SEQRES 24 A 354 GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR ASP SEQRES 25 A 354 PRO SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS PHE SEQRES 26 A 354 ASP MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU LYS SEQRES 27 A 354 GLU LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO GLY SEQRES 28 A 354 TYR ARG SER HET N0V A 401 50 HETNAM N0V (3R)-N-[3-(2-CYCLOPROPYLPYRIDIN-4-YL)-1H-INDAZOL-5-YL]- HETNAM 2 N0V 3-(METHOXYMETHYL)-1-(2-OXO-2-{4-[4-(PYRIMIDIN-2-YL) HETNAM 3 N0V PHENYL]-3,6-DIHYDROPYRIDIN-1(2H)-YL}ETHYL)PYRROLIDINE- HETNAM 4 N0V 3-CARBOXAMIDE FORMUL 2 N0V C39 H40 N8 O3 FORMUL 3 HOH *30(H2 O) HELIX 1 AA1 HIS A 59 PHE A 76 1 18 HELIX 2 AA2 LEU A 110 GLN A 117 1 8 HELIX 3 AA3 SER A 120 SER A 140 1 21 HELIX 4 AA4 LYS A 149 SER A 151 5 3 HELIX 5 AA5 THR A 188 ARG A 192 5 5 HELIX 6 AA6 ALA A 193 MET A 197 5 5 HELIX 7 AA7 SER A 206 ASN A 222 1 17 HELIX 8 AA8 HIS A 230 GLY A 243 1 14 HELIX 9 AA9 SER A 246 CYS A 252 1 7 HELIX 10 AB1 LEU A 256 SER A 264 1 9 HELIX 11 AB2 PRO A 272 PHE A 277 1 6 HELIX 12 AB3 ASP A 281 LEU A 292 1 12 HELIX 13 AB4 GLU A 301 HIS A 308 1 8 HELIX 14 AB5 PRO A 309 GLU A 312 5 4 HELIX 15 AB6 ASP A 316 GLU A 320 5 5 HELIX 16 AB7 PRO A 337 ALA A 350 1 14 HELIX 17 AB8 ARG A 351 GLN A 353 5 3 SHEET 1 AA1 2 GLU A 10 MET A 11 0 SHEET 2 AA1 2 VAL A 16 PHE A 17 -1 O PHE A 17 N GLU A 10 SHEET 1 AA2 5 TYR A 23 GLY A 32 0 SHEET 2 AA2 5 GLY A 35 ASP A 42 -1 O TYR A 41 N THR A 24 SHEET 3 AA2 5 VAL A 47 ILE A 54 -1 O VAL A 47 N ASP A 42 SHEET 4 AA2 5 VAL A 99 ASP A 104 -1 O GLN A 103 N ALA A 50 SHEET 5 AA2 5 ASP A 86 ARG A 89 -1 N ILE A 88 O TYR A 100 SHEET 1 AA3 3 THR A 108 ASP A 109 0 SHEET 2 AA3 3 LEU A 153 LEU A 155 -1 O LEU A 155 N THR A 108 SHEET 3 AA3 3 LEU A 161 ILE A 163 -1 O LYS A 162 N LEU A 154 SHEET 1 AA4 2 VAL A 143 LEU A 144 0 SHEET 2 AA4 2 ARG A 170 VAL A 171 -1 O ARG A 170 N LEU A 144 CISPEP 1 GLY A 20 PRO A 21 0 2.58 SITE 1 AC1 22 ILE A 29 ALA A 33 TYR A 34 ALA A 50 SITE 2 AC1 22 LYS A 52 ILE A 54 TYR A 62 ARG A 65 SITE 3 AC1 22 GLU A 69 GLN A 103 ASP A 104 MET A 106 SITE 4 AC1 22 GLU A 107 LYS A 112 SER A 151 ASN A 152 SITE 5 AC1 22 LEU A 154 CYS A 164 ASP A 165 GLY A 167 SITE 6 AC1 22 HOH A 510 HOH A 515 CRYST1 41.394 77.640 126.536 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024158 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012880 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007903 0.00000